Table 1.
Study number | Injection route | GNE-Lipoplex dose (total volume injected) | Treatment | Mice/cohort | Assessment |
---|---|---|---|---|---|
I | Intramuscular | 10 μg (80 μl) | GNE-lipoplex | 6 female, 6 male | Safety and toxicology, |
40 μg (80 μl) | GNE-lipoplex | 6 female, 6 male | GNE expression | ||
0 μg (80 μl) | Empty liposomes | 6 female, 6 male | |||
No injection | – | 6 female, 6 male | |||
II | Intramuscular | 40 μg (80 μl) | GNE-lipoplex | 15 female | GNE expression |
0 μg (80 μl) | Empty liposomes | 6 female | |||
III | Intravenous | 10 μg (200 μl) | GNE-lipoplex | 6 female, 6 male | Safety and toxicology, |
40 μg (200 μl) | GNE-lipoplex | 6 female, 6 male | GNE expression | ||
100 μg (200 μl) | GNE-lipoplex | 6 female, 6 male | |||
0 μg (200 μl) | Empty liposomes | 6 female, 6 male |